Dariusz Goźliński

"First, do no harm!"- This should be, the first rule for the communication activities in the field of pharmaceutical and legal.

Who am I?
Passionate about marketing and advertising. Strongly associated with the pharmaceutical industry and related. I create and I manage advertising campaigns including the use of social media in activities dedicated to doctors and patients. Professionally, I am the founder and managing director of the agency GreyTree. From 2002 r. I am associated with a limited marketing and advertising law. Among other things, worked with companies such as: Unilever, Jelfa, Sanitas Group, Adamed Healthcare, Blue Farma, Chance, Genexo, GAL, Heel Poland, Symphar, Sun Farm, Admiral, Ipsen, HiPP, Alpen Pharma or Krewel Meuselbach.

Yours,
Dariusz Goźliński
such. +48 22 628 53 61
e-mail: d.gozlinski(at)greytree.co

Pharma marketing w 2014

27 April 2014
Pharma marketing w 2014

Slowly end of the first quarter 2014 r. This is an unremarkable. Pharmaceutical marketing projects did not dominate the advertising space (beyond where every second radio ad “leczy and heals“). So today, I think it will look like marketing, including medical and pharmaceutical marketing in the rest of the year 2014 r.? In recent years we have had the accent of social media, the broader digital, mobile, and now it's time for ...?

Or maybe the question should be different? Is it at all Pharmaceutical and Medical are already so open to new ideas and trends from the world of marketing other products and services, to keep up with them? And maybe that's what will determine the direction of nursing?

Observing the trends beyond the world of pharmaceutical marketing, analyzing business decisions, which more often and boldly go beyond the existing patterns of action and communication channels, and – going beyond their own experience of agency and looking at the competition and watching the other reports and statements, conclude, industry that at least some of the companies. Increasingly, brand managers from asking these questions about unconventional ways to reach consumers / patients, and consequently increasing budgets go for promotion. For several years, the problem is no longer a high dose of humor in the campaigns, and yet a few years ago, our industry has largely been fairly conservative. Also, not without significance is the openness and social acceptance, civilization changes of recent years. Until recently, some problems, which does not touch us talked loudly, and now? Now more and more often we see the advertising of dietary supplements for men, Internet and even read about healthy lifestyles, etc.. For this we have a new model of consumer, which is an integral part of life virtual world of social media and Google, where we spend more and more of your time.

In an era of increasingly intensive competitive advantage you gain, who quickly adapt to changes, try the more efficient use of their resources, and to have the courage to be among the pioneers of new trends. So the rest of the year 2014 will be a year of re-marketing (retargeting), real-time marketing i micro-video? Finally already slowly passing 2013 r. increasingly began to use them, and in the case micro-video (movies Instagram services Comes) we have seen a sharp increase in interest from the internet (yet also the most common among them is our target group). There are many questions, but it is certain that, the pharmaceutical industry (more than strictly medical - in my opinion, still quite cautious and conservative) like never before is prepared for use in marketing trends. Behind it is not only a large capital, access Big Data, Closed Loop Marketing, edetailing.co (increasingly detailed and aggregated information about consumers and patients), but above all the need to gain competitive advantage in the market supplements, cosmetics and OTC and Rx. I hope, therefore,, the remainder of the year 2014 year will be a time of bold and wise decisions in the industry and not, as the first four months, domination exaggerated caution.

Comments

Comments

Share this Story

Related Posts

Automatic translation:

Twitter